VVOS - Vivos Therapeutics GAAP EPS of -$1.04 revenue of $16.02M March, 31 2023 03:03 AM Vivos Therapeutics Inc. 2023-03-31 03:03:55 ET Vivos Therapeutics press release ( NASDAQ: VVOS ): FY GAAP EPS of -$1.04. Revenue of $16.02M (-5.2% Y/Y). For further details see: Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M